South Korea to administer COVID-19 vaccines to 12m people

South Korea to administer COVID-19 vaccines to 12m people

COVID-19: AstraZeneca vaccine is safe — NMA

South Korea on Monday said that it plans to administer the first jab of Coronavirus (COVID-19) vaccines to 12-million people by the end of June out of the country’s 52-million population.

The country launched its mass vaccination campaign on Feb. 26, administering the first shot of vaccines to a total of 588,958 people. The people who had received the injection are mostly patients aged 65 or lower at nursing homes and medical staff treating COVID-19 patients as of Monday morning.

ALSO READ: AstraZeneca vaccine not linked to clotting ― Co-developer

The first-phase administration was set to be completed by the end of March, according to the Korea Disease Control and Prevention Agency (KDCA).

The second-phase administration, slated to last from the ending of March to June, will involve six major groups, including patients and employees at nursing facilities aged 65 or higher, and virus-vulnerable facilities for the elderly, the disabled and the homeless.

Among the general public, those aged 65 or older will get inoculated during the first half.

ALSO READ: LEAP Africa mourns board member Seyi Bickersteth

Vaccine recipients on the list will include a part of teachers and healthcare personnel in preschools, daycare centres and primary schools; patients with chronic kidney failure and chronic severe respiratory disease.

Others are socially required personnel and health, medical staff such as flight attendants, police, firefighters, soldiers and staff in hospitals and pharmacies. The third-phase administration was scheduled to begin in July, mostly focusing on the general public.

South Korea aimed to get 70 per cent of its population vaccinated by September and to form a herd immunity no later than November.

Vanguard News Nigeria

The post South Korea to administer COVID-19 vaccines to 12m people appeared first on Vanguard News.

This post was originally published on this site

About Author

Write a Comment

Your e-mail address will not be published.
Required fields are marked*